These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38088673)

  • 1. Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis.
    Poznyak AV; Kashirskikh DA; Postnov AY; Popov MA; Sukhorukov VN; Orekhov AN
    Braz J Med Biol Res; 2023; 56():e12972. PubMed ID: 38088673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sialic acids in the initiation of atherosclerosis.
    Poznyak AV; Zhang D; Grechko AV; Wu WK; Orekhov AN
    Minerva Cardioangiol; 2020 Aug; 68(4):359-364. PubMed ID: 32472985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic acid metabolism as a potential therapeutic target of atherosclerosis.
    Zhang C; Chen J; Liu Y; Xu D
    Lipids Health Dis; 2019 Sep; 18(1):173. PubMed ID: 31521172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid content of LDL in coronary artery disease: no evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: relation between desialylation and in vitro peroxidation.
    Chappey B; Beyssen B; Foos E; Ledru F; Guermonprez JL; Gaux JC; Myara I
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):876-83. PubMed ID: 9633926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
    Orekhov AN; Tertov VV; Mukhin DN
    Atherosclerosis; 1991 Feb; 86(2-3):153-61. PubMed ID: 1872910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialidases: Therapeutic and Antiatherogenic Potential.
    Sukhorukov VN; Karagodin VP; Zakiev ER; Grechko AV; Orekhov AN
    Curr Pharm Des; 2017; 23(31):4696-4701. PubMed ID: 28911304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atherogenic modification of low-density lipoproteins].
    Sukhorukov VN; Karagodin VP; Orekhov AN
    Biomed Khim; 2016 May; 62(4):391-402. PubMed ID: 27562992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of radical reactions in desialylation of LDL.
    Tanaka K; Tokumaru S; Kojo S
    FEBS Lett; 1997 Aug; 413(2):202-4. PubMed ID: 9280282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sialylation of plasma lipoproteins.
    Millar JS
    Atherosclerosis; 2001 Jan; 154(1):1-13. PubMed ID: 11137077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis.
    Poznyak AV; Kashirskikh DA; Sukhorukov VN; Kalmykov V; Omelchenko AV; Orekhov AN
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and structural basis of sialic acid utilization by gut microbes.
    Bell A; Severi E; Owen CD; Latousakis D; Juge N
    J Biol Chem; 2023 Mar; 299(3):102989. PubMed ID: 36758803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mitochondria in cardiovascular diseases related to atherosclerosis.
    Glanz VY; Sobenin IA; Grechko AV; Yet SF; Orekhov AN
    Front Biosci (Elite Ed); 2020 Jan; 12(1):102-112. PubMed ID: 31585872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resialylation of sialic acid deficit vascular endothelium, circulating cells and macromolecules may counteract the development of atherosclerosis: a hypothesis.
    Lindberg G
    Atherosclerosis; 2007 Jun; 192(2):243-5. PubMed ID: 17420020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human species-specific loss of CMP-
    Kawanishi K; Dhar C; Do R; Varki N; Gordts PLSM; Varki A
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16036-16045. PubMed ID: 31332008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD.
    Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.
    Libby P; Alroy J; Pereira ME
    J Clin Invest; 1986 Jan; 77(1):127-35. PubMed ID: 3080470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic acid diversity in the human gut: Molecular impacts and tools for future discovery.
    Sokolovskaya OM; Tan MW; Wolan DW
    Curr Opin Struct Biol; 2022 Aug; 75():102397. PubMed ID: 35653953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontypeable
    Ng PSK; Day CJ; Atack JM; Hartley-Tassell LE; Winter LE; Marshanski T; Padler-Karavani V; Varki A; Barenkamp SJ; Apicella MA; Jennings MP
    mBio; 2019 May; 10(3):. PubMed ID: 31064827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.